文献速递先天性心脏病外科

Fontan通路生长与长期结局的关联

Growth of the Fontan pathway and its association with long-term outcomes.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-07-29

本研究回顾性分析2000至2017年在本机构接受Fontan手术并有术后CT/MRI评估的207例患者(LT 166例,EC 41例),通过三维分割和计算流体力学评估通路几何与血流动力学。结果显示LT通路体积显著增长(1.6 mL/年,P < .001),EC通路体积无显著变化(0.4 mL/年,P = .07);LT患者Fontan失败率低于EC患者(P = .002),中介分析提示体积介导了LT技术10年保护效应的约20%。

要点

  • LT Fontan通路体积年增长1.6 mL(P < .001),EC通路无显著变化(0.4 mL/年,P = .07)。
  • EC组索引功率损失(iPL)显著增加(P = .018),LT组保持稳定。
  • LT患者Fontan失败率低于EC患者(P = .002),体积介导约20%的10年保护效应。

核心结论

  • LT Fontan通路较EC通路具有更优的生长特性和持续的血流效率,且与更好的结局相关,可能归因于有利的几何形态。

研究设计与样本

  • 回顾性研究,纳入2000至2017年在本机构接受Fontan手术并有术后CT/MRI评估的患者207例(LT 166例,EC 41例),其中69例(LT 54例,EC 15例)有多次术后CT/MRI检查。

主要发现

  • LT队列Fontan通路体积显著增加(1.6 mL/年;P < .001),EC队列无显著变化(0.4 mL/年;P = .07)。
  • 按体表面积调整后,LT Fontan体积仍增加(P = .006),EC Fontan体积显著减少(P = .026)。
  • LT Fontan的iPL保持稳定,EC队列iPL显著增加(P = .018)。
  • LT患者Fontan失败率低于EC患者(P = .002,log-rank检验)。
  • 中介分析显示体积介导了LT技术对10年Fontan失败保护效应的约20%。

关键数值与推荐

  • Fontan失败定义为死亡、心脏移植、乳糜胸、蛋白丢失性肠病、塑性支气管炎和肝功能障碍的复合终点。
  • iPL通过计算流体力学结合患者特异性血流测量和分割估计。

临床怎么用

  • LT Fontan通路在生长和血流效率方面优于EC通路,临床选择术式时可考虑其几何优势对长期结局的潜在益处。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize longitudinal changes in lateral tunnel (LT) and extracardiac conduit (EC) Fontan pathway geometry and flow dynamics and to investigate whether these parameters mediate differences in outcomes by Fontan type. METHODS: Patients who underwent Fontan at our institution between 2000 and 2017 and were evaluated with post-Fontan computed tomography (CT)/magnetic resonance imaging (MRI) were reviewed retrospectively. Three-dimensional segmentations of the Fontan pathways were generated. Indexed power loss (iPL) was estimated using computational fluid dynamics in the context of patient-specific flow measurements and segmentations. Fontan failure was defined as a composite of mortality, heart transplantation, chylothorax, protein-losing enteropathy, plastic bronchitis, and hepatic dysfunction. RESULTS: Of 207 patients (LT, 166; EC, 41) who met the study criteria, 69 (LT, 54; EC, 15) had multiple post-Fontan CT/MRI examinations. Fontan pathway volume increased significantly within the LT cohort (1.6 mL/year; P < .001), but there was no significant change in the volume of EC Fontans (0.4 mL/year; P = .07). When adjusting for body surface area, LT Fontans continued to display increased volume (P = .006), while EC Fontans showed marked decreases (P = .026). The iPL of LT Fontans remained stable; however, there was a significant increase in iPL for patients in the EC cohort (P = .018). LT patients had lower rates of Fontan failure compared to EC patients (P = .002, log-rank test). Mediation analysis revealed that volume mediated ∼20% of the protective effects of the LT technique on the occurrence of Fontan failure at 10 years. CONCLUSIONS: LT Fontan pathways exhibited superior growth characteristics and sustained flow efficiency compared to EC Fontan pathways. The LT technique also was associated with improved outcomes, a finding that may be attributable to favorable geometry.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Verma A, Dafflisio G, Govindarajan V, et al. Growth of the Fontan pathway and its association with long-term outcomes. J Thorac Cardiovasc Surg. 2025. PMID: 40744160. doi:10.1016/j.jtcvs.2025.07.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。